Ultrasonic Scalpels Market by Product (Cavitron Ultrasonic Surgical Aspirator, Harmonic Scalpel), Mode (Laparoscopic Surgery, Open Surgery), Application, End User, Distribution Channel - Global Forecast 2025-2032
Description
The Ultrasonic Electrosurgical Devices Market was valued at USD 2.80 billion in 2024 and is projected to grow to USD 3.21 billion in 2025, with a CAGR of 15.30%, reaching USD 8.77 billion by 2032.
A comprehensive introduction framing clinical imperatives, technological maturation, and procurement drivers that define the ultrasonic electrosurgical device ecosystem
The adoption and evolution of ultrasonic electrosurgical devices reflect a convergence of clinical need, engineering advancement, and shifting care delivery models. Historically, surgeons valued technologies that reduce collateral thermal damage and improve hemostasis; ultrasonic instruments have matured to meet those imperatives while enabling greater precision in minimally invasive and open procedures. As a result, hospitals and ambulatory centers continually reassess surgical toolkits to balance clinical outcomes with throughput and cost-efficiency. These dynamics influence purchasing, contracting, and product development priorities across device manufacturers and healthcare providers.
Today’s landscape is shaped by iterative device refinements, expanding procedural indications, and intensifying scrutiny on product lifecycle management. Newer generator platforms, ergonomic handpieces, and a growing range of consumables are improving integration within operating rooms and robotic systems. At the same time, procurement stakeholders increasingly evaluate total cost of ownership, reprocessing workflows, and compatibility with existing infrastructure. In response, manufacturers emphasize evidence generation, surgeon training, and service ecosystems. Consequently, effective market strategies must align clinical value propositions with operational realities to accelerate adoption and sustain long-term utilization.
An analytical overview of transformative clinical, technological, regulatory, and commercial shifts that are redefining ultrasonic electrosurgical device strategies
Recent transformative shifts are reshaping how ultrasonic electrosurgical devices are designed, regulated, and purchased, creating new inflection points for stakeholders across the value chain. Advances in miniaturization and energy control have strengthened the clinical case for ultrasonic platforms, enabling surgeons to perform delicate dissections with reduced thermal spread and improved hemostasis. Concurrently, integration with robotic-assisted systems has progressed from proof-of-concept to routine adjunctive use in selected specialties, altering workflow patterns and expectations for device interoperability.
Supply chain reconfiguration and heightened regulatory scrutiny have also driven manufacturers to re-evaluate sourcing strategies and device lifecycle documentation. Additionally, evolving hospital procurement models emphasize bundled service offerings and outcome-driven contracting, encouraging vendors to present evidence that links device use to measurable clinical and economic benefits. Finally, the market is witnessing a push toward differentiated consumable portfolios and hybrid reusable–single-use models, reflecting a desire to optimize both infection control and cost. These shifts collectively demand cross-functional responses from R&D, clinical affairs, and commercial teams to maintain competitiveness and relevance.
A detailed assessment of how the 2025 United States tariff measures have reshaped sourcing, pricing, and supply chain resilience across ultrasonic electrosurgical device supply chains
The cumulative impact of newly imposed United States tariffs in 2025 has introduced material complexities across procurement, supply chain planning, and pricing strategies for devices and components tied to ultrasonic electrosurgical platforms. Import levies on specific components and finished goods have increased landed costs for some manufacturers, forcing re-evaluation of sourcing geographies and supplier contracts. In response, many value chain participants initiated near-shore procurement conversations, explored tariff mitigation mechanisms such as tariff classification reviews, and accelerated supplier qualification efforts to preserve margin and delivery reliability.
Beyond direct cost implications, tariffs have influenced commercial behavior by accelerating supplier consolidation and prompting inventory policy shifts. Hospitals and distributors reassessed stocking strategies to buffer against price volatility, while device companies revisited contract terms to protect both revenue and customer relationships. At the same time, some manufacturers intensified investments in domestic manufacturing capabilities to reduce exposure to cross-border tariffs and to strengthen compliance posture. Overall, the tariff environment has heightened the importance of agile supply chain design, scenario-based financial modeling, and proactive stakeholder communication as prerequisites for sustaining market access and competitive differentiation.
An insightful synthesis of multi-dimensional segmentation that clarifies clinical use cases, purchasing behaviors, and product design imperatives for ultrasonic electrosurgical devices
Segmentation insights reveal heterogeneous adoption patterns and value drivers across device types, procedure modalities, applications, end users, and usage models. Based on Device Type, market considerations differentiate between Accessories And Consumables, Generator, and Handpiece; accessories and consumables influence recurring revenue dynamics and clinician preferences, generators anchor system-level compatibility and upgrade pathways, and handpieces drive ergonomic and performance differentiation. Based on Procedure Type, the clinical environment spans Laparoscopic Surgery, Open Surgery, and Robotic-Assisted Surgery; each modality imposes distinct requirements for instrument profile, energy modulation, and compatibility with ancillary platforms. Based on Application, devices are assessed across Cardiovascular Surgery, General Surgery, Gynecology, Orthopedic Surgery, and Urology, where procedural complexity and bleeding risk shape clinical value propositions and evidence requirements.
Based on End User, purchasing behavior and utilization metrics vary among Ambulatory Surgical Centers, Hospitals, and Specialty Clinics; ambulatory settings prioritize throughput and cost-per-procedure, hospitals emphasize versatility and integration with in-hospital systems, and specialty clinics focus on niche procedural expertise and device specialization. Finally, Based on Usage, device strategies differentiate between Reusable Devices and Single Use Devices. The Reusable Devices category is further subdivided into Reusable Accessories and Reusable Handpieces, which are evaluated for reprocessing costs and durability. The Single Use Devices category is further subdivided into Single Use Accessories and Single Use Handpieces, where infection control, convenience, and per-procedure costs drive adoption. Together, these segmentation lenses provide layered insight into where clinical need, procurement priorities, and product design intersect to determine market positioning and commercialization tactics.
A regional analysis articulating how divergent healthcare systems, regulatory frameworks, and procurement priorities shape ultrasonic electrosurgical device adoption across global markets
Regional dynamics significantly influence adoption trajectories and commercial opportunities for ultrasonic electrosurgical devices across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, healthcare delivery systems continue to emphasize minimally invasive surgery and bundled payment models, which elevates interest in devices that demonstrably reduce complications and length of stay. Procurement cycles in this region often prioritize clinical evidence and total cost considerations, shaping how new devices are introduced and scaled.
In Europe, Middle East & Africa, regulatory harmonization efforts and variable healthcare infrastructure create a layered market environment. Certain European countries are early adopters of energy-based surgical tools, driven by robust clinical trial networks and reimbursement mechanisms, while other markets within the region present opportunities tied to capacity building and investments in surgical modernization. Asia-Pacific demonstrates rapid procedural volume growth and a propensity for domestic manufacturing innovation, prompting multinational and local players to adapt strategies that balance affordability with performance. Transitional factors such as regulatory timelines, local manufacturing incentives, and public health investment profiles continue to drive regional differentiation in product positioning and commercial models.
A strategic review of competitive dynamics highlighting innovation priorities, service ecosystems, and partnership strategies that determine market leadership in ultrasonic devices
Competitive dynamics in the ultrasonic electrosurgical device arena emphasize innovation breadth, service ecosystems, and partnerships rather than purely transactional product sales. Leading organizations are allocating R&D resources to improve energy efficiency, instrument ergonomics, and system connectivity to operating room workflows. Strategic priorities include expanding consumable portfolios to generate recurring revenue, embedding digital features that support performance analytics, and deepening clinical education programs to accelerate adoption among surgical subspecialties.
Additionally, collaboration between device firms and robotic system integrators has intensified, with commercial strategies focusing on compatibility and co-marketing arrangements. Smaller, nimble entrants often target niche clinical segments or highly differentiated consumables to gain footholds, while larger incumbents leverage service networks and hospital relationships to defend installed base positions. Across the competitive landscape, companies are increasingly judged by their ability to demonstrate clinical outcomes, streamline procurement and servicing, and offer flexible purchasing models that align with provider budget cycles.
A pragmatic set of strategic and operational recommendations designed to help manufacturers and healthcare providers accelerate adoption, strengthen resilience, and capture clinical value
Industry leaders should pursue a set of actionable recommendations that align product development, commercial models, and operational resilience with emerging market realities. First, prioritize modular system architectures that enable incremental upgrades and multi-generational compatibility to protect installed base value and support long procurement cycles. Second, invest in robust clinical evidence generation targeted at procedure types and applications where ultrasonic devices deliver the clearest outcomes, pairing health-economic analyses with clinical data to shorten adoption timelines.
Third, optimize supply chains by diversifying sourcing, qualifying near-shore suppliers, and implementing tariff mitigation strategies to reduce exposure to trade policy shifts. Fourth, tailor commercial models to end-user segments: offer subscription or bundled service options for hospitals and cost-per-case propositions for ambulatory centers. Fifth, develop clear reprocessing guidance and service frameworks for reusable devices while defining premium value propositions for single-use offerings that emphasize infection control and workflow efficiency. Finally, pursue targeted partnerships with robotic platform providers and clinical centers of excellence to co-develop integrated solutions and accelerate surgeon training.
A transparent explanation of the mixed-method research approach combining primary interviews, secondary intelligence, and analytical triangulation to validate insights
The research methodology underpinning this executive summary blends qualitative and quantitative approaches to ensure rigorous, actionable findings. Primary research included structured interviews with clinical leaders, supply chain managers, and procurement specialists across ambulatory and hospital settings to capture real-world adoption drivers, procedural constraints, and purchasing rationales. Secondary research drew on regulatory filings, published clinical literature, patent activity, and publicly available policy documents to validate trends in device design, safety considerations, and reimbursement contexts.
Analytical techniques incorporated cross-sectional segmentation mapping to align device attributes with procedure types and end-user needs, as well as scenario analysis to assess the implications of supply chain disruptions and tariff changes. Triangulation across data sources ensured that conclusions reflect convergent evidence rather than isolated signals. Where appropriate, findings were stress-tested through expert review panels to refine recommendations and ensure relevance for commercial strategy, product development, and clinical affairs teams.
A conclusive synthesis emphasizing how integrated clinical evidence, adaptive commercial models, and resilient operations will determine long-term success for ultrasonic device stakeholders
In conclusion, ultrasonic electrosurgical devices occupy a pivotal role at the intersection of clinical efficacy and operational efficiency, with innovation and commercial strategy determining which solutions scale effectively. Device evolution has reduced thermal injury and improved hemostatic control, reinforcing clinical adoption across a widening set of surgical specialties. At the same time, regulatory expectations, tariff environments, and procurement models demand that manufacturers align technical advantages with compelling economic narratives and resilient supply chains.
Moving forward, successful market participants will be those that translate clinical performance into verifiable outcomes, structure flexible commercial offerings for diverse end users, and fortify supply chain and manufacturing strategies against policy and logistical shocks. Cross-functional collaboration between R&D, clinical affairs, supply chain, and commercial teams will be essential to realize the full potential of ultrasonic technologies in improving surgical outcomes and operational metrics.
Note: PDF & Excel + Online Access - 1 Year
A comprehensive introduction framing clinical imperatives, technological maturation, and procurement drivers that define the ultrasonic electrosurgical device ecosystem
The adoption and evolution of ultrasonic electrosurgical devices reflect a convergence of clinical need, engineering advancement, and shifting care delivery models. Historically, surgeons valued technologies that reduce collateral thermal damage and improve hemostasis; ultrasonic instruments have matured to meet those imperatives while enabling greater precision in minimally invasive and open procedures. As a result, hospitals and ambulatory centers continually reassess surgical toolkits to balance clinical outcomes with throughput and cost-efficiency. These dynamics influence purchasing, contracting, and product development priorities across device manufacturers and healthcare providers.
Today’s landscape is shaped by iterative device refinements, expanding procedural indications, and intensifying scrutiny on product lifecycle management. Newer generator platforms, ergonomic handpieces, and a growing range of consumables are improving integration within operating rooms and robotic systems. At the same time, procurement stakeholders increasingly evaluate total cost of ownership, reprocessing workflows, and compatibility with existing infrastructure. In response, manufacturers emphasize evidence generation, surgeon training, and service ecosystems. Consequently, effective market strategies must align clinical value propositions with operational realities to accelerate adoption and sustain long-term utilization.
An analytical overview of transformative clinical, technological, regulatory, and commercial shifts that are redefining ultrasonic electrosurgical device strategies
Recent transformative shifts are reshaping how ultrasonic electrosurgical devices are designed, regulated, and purchased, creating new inflection points for stakeholders across the value chain. Advances in miniaturization and energy control have strengthened the clinical case for ultrasonic platforms, enabling surgeons to perform delicate dissections with reduced thermal spread and improved hemostasis. Concurrently, integration with robotic-assisted systems has progressed from proof-of-concept to routine adjunctive use in selected specialties, altering workflow patterns and expectations for device interoperability.
Supply chain reconfiguration and heightened regulatory scrutiny have also driven manufacturers to re-evaluate sourcing strategies and device lifecycle documentation. Additionally, evolving hospital procurement models emphasize bundled service offerings and outcome-driven contracting, encouraging vendors to present evidence that links device use to measurable clinical and economic benefits. Finally, the market is witnessing a push toward differentiated consumable portfolios and hybrid reusable–single-use models, reflecting a desire to optimize both infection control and cost. These shifts collectively demand cross-functional responses from R&D, clinical affairs, and commercial teams to maintain competitiveness and relevance.
A detailed assessment of how the 2025 United States tariff measures have reshaped sourcing, pricing, and supply chain resilience across ultrasonic electrosurgical device supply chains
The cumulative impact of newly imposed United States tariffs in 2025 has introduced material complexities across procurement, supply chain planning, and pricing strategies for devices and components tied to ultrasonic electrosurgical platforms. Import levies on specific components and finished goods have increased landed costs for some manufacturers, forcing re-evaluation of sourcing geographies and supplier contracts. In response, many value chain participants initiated near-shore procurement conversations, explored tariff mitigation mechanisms such as tariff classification reviews, and accelerated supplier qualification efforts to preserve margin and delivery reliability.
Beyond direct cost implications, tariffs have influenced commercial behavior by accelerating supplier consolidation and prompting inventory policy shifts. Hospitals and distributors reassessed stocking strategies to buffer against price volatility, while device companies revisited contract terms to protect both revenue and customer relationships. At the same time, some manufacturers intensified investments in domestic manufacturing capabilities to reduce exposure to cross-border tariffs and to strengthen compliance posture. Overall, the tariff environment has heightened the importance of agile supply chain design, scenario-based financial modeling, and proactive stakeholder communication as prerequisites for sustaining market access and competitive differentiation.
An insightful synthesis of multi-dimensional segmentation that clarifies clinical use cases, purchasing behaviors, and product design imperatives for ultrasonic electrosurgical devices
Segmentation insights reveal heterogeneous adoption patterns and value drivers across device types, procedure modalities, applications, end users, and usage models. Based on Device Type, market considerations differentiate between Accessories And Consumables, Generator, and Handpiece; accessories and consumables influence recurring revenue dynamics and clinician preferences, generators anchor system-level compatibility and upgrade pathways, and handpieces drive ergonomic and performance differentiation. Based on Procedure Type, the clinical environment spans Laparoscopic Surgery, Open Surgery, and Robotic-Assisted Surgery; each modality imposes distinct requirements for instrument profile, energy modulation, and compatibility with ancillary platforms. Based on Application, devices are assessed across Cardiovascular Surgery, General Surgery, Gynecology, Orthopedic Surgery, and Urology, where procedural complexity and bleeding risk shape clinical value propositions and evidence requirements.
Based on End User, purchasing behavior and utilization metrics vary among Ambulatory Surgical Centers, Hospitals, and Specialty Clinics; ambulatory settings prioritize throughput and cost-per-procedure, hospitals emphasize versatility and integration with in-hospital systems, and specialty clinics focus on niche procedural expertise and device specialization. Finally, Based on Usage, device strategies differentiate between Reusable Devices and Single Use Devices. The Reusable Devices category is further subdivided into Reusable Accessories and Reusable Handpieces, which are evaluated for reprocessing costs and durability. The Single Use Devices category is further subdivided into Single Use Accessories and Single Use Handpieces, where infection control, convenience, and per-procedure costs drive adoption. Together, these segmentation lenses provide layered insight into where clinical need, procurement priorities, and product design intersect to determine market positioning and commercialization tactics.
A regional analysis articulating how divergent healthcare systems, regulatory frameworks, and procurement priorities shape ultrasonic electrosurgical device adoption across global markets
Regional dynamics significantly influence adoption trajectories and commercial opportunities for ultrasonic electrosurgical devices across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, healthcare delivery systems continue to emphasize minimally invasive surgery and bundled payment models, which elevates interest in devices that demonstrably reduce complications and length of stay. Procurement cycles in this region often prioritize clinical evidence and total cost considerations, shaping how new devices are introduced and scaled.
In Europe, Middle East & Africa, regulatory harmonization efforts and variable healthcare infrastructure create a layered market environment. Certain European countries are early adopters of energy-based surgical tools, driven by robust clinical trial networks and reimbursement mechanisms, while other markets within the region present opportunities tied to capacity building and investments in surgical modernization. Asia-Pacific demonstrates rapid procedural volume growth and a propensity for domestic manufacturing innovation, prompting multinational and local players to adapt strategies that balance affordability with performance. Transitional factors such as regulatory timelines, local manufacturing incentives, and public health investment profiles continue to drive regional differentiation in product positioning and commercial models.
A strategic review of competitive dynamics highlighting innovation priorities, service ecosystems, and partnership strategies that determine market leadership in ultrasonic devices
Competitive dynamics in the ultrasonic electrosurgical device arena emphasize innovation breadth, service ecosystems, and partnerships rather than purely transactional product sales. Leading organizations are allocating R&D resources to improve energy efficiency, instrument ergonomics, and system connectivity to operating room workflows. Strategic priorities include expanding consumable portfolios to generate recurring revenue, embedding digital features that support performance analytics, and deepening clinical education programs to accelerate adoption among surgical subspecialties.
Additionally, collaboration between device firms and robotic system integrators has intensified, with commercial strategies focusing on compatibility and co-marketing arrangements. Smaller, nimble entrants often target niche clinical segments or highly differentiated consumables to gain footholds, while larger incumbents leverage service networks and hospital relationships to defend installed base positions. Across the competitive landscape, companies are increasingly judged by their ability to demonstrate clinical outcomes, streamline procurement and servicing, and offer flexible purchasing models that align with provider budget cycles.
A pragmatic set of strategic and operational recommendations designed to help manufacturers and healthcare providers accelerate adoption, strengthen resilience, and capture clinical value
Industry leaders should pursue a set of actionable recommendations that align product development, commercial models, and operational resilience with emerging market realities. First, prioritize modular system architectures that enable incremental upgrades and multi-generational compatibility to protect installed base value and support long procurement cycles. Second, invest in robust clinical evidence generation targeted at procedure types and applications where ultrasonic devices deliver the clearest outcomes, pairing health-economic analyses with clinical data to shorten adoption timelines.
Third, optimize supply chains by diversifying sourcing, qualifying near-shore suppliers, and implementing tariff mitigation strategies to reduce exposure to trade policy shifts. Fourth, tailor commercial models to end-user segments: offer subscription or bundled service options for hospitals and cost-per-case propositions for ambulatory centers. Fifth, develop clear reprocessing guidance and service frameworks for reusable devices while defining premium value propositions for single-use offerings that emphasize infection control and workflow efficiency. Finally, pursue targeted partnerships with robotic platform providers and clinical centers of excellence to co-develop integrated solutions and accelerate surgeon training.
A transparent explanation of the mixed-method research approach combining primary interviews, secondary intelligence, and analytical triangulation to validate insights
The research methodology underpinning this executive summary blends qualitative and quantitative approaches to ensure rigorous, actionable findings. Primary research included structured interviews with clinical leaders, supply chain managers, and procurement specialists across ambulatory and hospital settings to capture real-world adoption drivers, procedural constraints, and purchasing rationales. Secondary research drew on regulatory filings, published clinical literature, patent activity, and publicly available policy documents to validate trends in device design, safety considerations, and reimbursement contexts.
Analytical techniques incorporated cross-sectional segmentation mapping to align device attributes with procedure types and end-user needs, as well as scenario analysis to assess the implications of supply chain disruptions and tariff changes. Triangulation across data sources ensured that conclusions reflect convergent evidence rather than isolated signals. Where appropriate, findings were stress-tested through expert review panels to refine recommendations and ensure relevance for commercial strategy, product development, and clinical affairs teams.
A conclusive synthesis emphasizing how integrated clinical evidence, adaptive commercial models, and resilient operations will determine long-term success for ultrasonic device stakeholders
In conclusion, ultrasonic electrosurgical devices occupy a pivotal role at the intersection of clinical efficacy and operational efficiency, with innovation and commercial strategy determining which solutions scale effectively. Device evolution has reduced thermal injury and improved hemostatic control, reinforcing clinical adoption across a widening set of surgical specialties. At the same time, regulatory expectations, tariff environments, and procurement models demand that manufacturers align technical advantages with compelling economic narratives and resilient supply chains.
Moving forward, successful market participants will be those that translate clinical performance into verifiable outcomes, structure flexible commercial offerings for diverse end users, and fortify supply chain and manufacturing strategies against policy and logistical shocks. Cross-functional collaboration between R&D, clinical affairs, supply chain, and commercial teams will be essential to realize the full potential of ultrasonic technologies in improving surgical outcomes and operational metrics.
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
186 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Integration of ultrasonic scalpels with robotic surgery platforms to improve precision and control
- 5.2. Development of single-use disposable ultrasonic scalpels addressing sterilization and infection concerns
- 5.3. Advancements in piezoelectric transducer materials for higher efficiency and reduced device footprint
- 5.4. Expansion of minimally invasive and endoscopic procedures using miniaturized ultrasonic scalpels for complex anatomy
- 5.5. Incorporation of real-time tissue characterization sensors in ultrasonic scalpels for optimized energy delivery
- 5.6. Emerging reimbursement policies and regulatory harmonization driving global ultrasonic scalpel adoption rates
- 5.7. AI-driven analytics integration in ultrasonic scalpel systems providing predictive maintenance and performance insights
- 5.8. Sustainable design initiatives promoting eco-friendly disposable components in ultrasonic scalpel manufacturing processes
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Ultrasonic Scalpels Market, by Product
- 8.1. Cavitron Ultrasonic Surgical Aspirator
- 8.2. Harmonic Scalpel
- 9. Ultrasonic Scalpels Market, by Mode
- 9.1. Laparoscopic Surgery
- 9.2. Open Surgery
- 10. Ultrasonic Scalpels Market, by Application
- 10.1. General Surgery
- 10.2. Gynecology
- 10.3. Oncology
- 10.4. Orthopedics
- 10.5. Urology
- 11. Ultrasonic Scalpels Market, by End User
- 11.1. Ambulatory Surgery Centers
- 11.2. Hospitals
- 11.3. Specialty Clinics
- 12. Ultrasonic Scalpels Market, by Distribution Channel
- 12.1. Direct Sales
- 12.2. Distributors
- 13. Ultrasonic Scalpels Market, by Region
- 13.1. Americas
- 13.1.1. North America
- 13.1.2. Latin America
- 13.2. Europe, Middle East & Africa
- 13.2.1. Europe
- 13.2.2. Middle East
- 13.2.3. Africa
- 13.3. Asia-Pacific
- 14. Ultrasonic Scalpels Market, by Group
- 14.1. ASEAN
- 14.2. GCC
- 14.3. European Union
- 14.4. BRICS
- 14.5. G7
- 14.6. NATO
- 15. Ultrasonic Scalpels Market, by Country
- 15.1. United States
- 15.2. Canada
- 15.3. Mexico
- 15.4. Brazil
- 15.5. United Kingdom
- 15.6. Germany
- 15.7. France
- 15.8. Russia
- 15.9. Italy
- 15.10. Spain
- 15.11. China
- 15.12. India
- 15.13. Japan
- 15.14. Australia
- 15.15. South Korea
- 16. Competitive Landscape
- 16.1. Market Share Analysis, 2024
- 16.2. FPNV Positioning Matrix, 2024
- 16.3. Competitive Analysis
- 16.3.1. Axon Medical Solutions
- 16.3.2. Bioventus Inc.
- 16.3.3. BOWA-Electronic GmbH & Co. KG
- 16.3.4. Cadence Inc.
- 16.3.5. Duomed Belgium
- 16.3.6. Elite Medical
- 16.3.7. Hangzhou Rex Medical Instrument Co., Ltd.
- 16.3.8. Johnson & Johnson Services, Inc.
- 16.3.9. Lepu Medical Technology(Beijing)Co., Ltd.
- 16.3.10. LISI Group
- 16.3.11. Lotus Surgicals Pvt. Ltd.
- 16.3.12. Medtronic PLC
- 16.3.13. Olympus Corporation
- 16.3.14. Rivolution GmbH
- 16.3.15. SHANGHAI LZQ PRECISION TOOL CO., LTD
- 16.3.16. Shenzhen Jiayuanda Technology Co.,Ltd.
- 16.3.17. Sonics & Materials, Inc.
- 16.3.18. Stryker Corporation
- 16.3.19. Surgnova Healthcare Technologies
- 16.3.20. Söring GmbH
- 16.3.21. Wuhan BBT Mini-Invasive Medical Tech. Co., Ltd
- 16.3.22. Heal Force Bio-Meditech Holdings Limited
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
